Unknown

Dataset Information

0

Pharmacokinetics and Pharmacodynamics of Intensive Antituberculosis Treatment of Tuberculous Meningitis.


ABSTRACT: The most effective antituberculosis drug treatment regimen for tuberculous meningitis is uncertain. We conducted a randomized controlled trial comparing standard treatment with a regimen intensified by rifampin 15 mg/kg and levofloxacin for the first 60 days. The intensified regimen did not improve survival or any other outcome. We therefore conducted a nested pharmacokinetic/pharmacodynamic study in 237 trial participants to define exposure-response relationships that might explain the trial results and improve future therapy. Rifampin 15 mg/kg increased plasma and cerebrospinal fluid (CSF) exposures compared with 10 mg/kg: day 14 exposure increased from 48.2 hour·mg/L (range 18.2-93.8) to 82.5 hour·mg/L (range 8.7-161.0) in plasma and from 3.5 hour·mg/L (range 1.2-9.6) to 6.0 hour·mg/L (range 0.7-15.1) in CSF. However, there was no relationship between rifampin exposure and survival. In contrast, we found that isoniazid exposure was associated with survival, with low exposure predictive of death, and was linked to a fast metabolizer phenotype. Higher doses of isoniazid should be investigated, especially in fast metabolizers.

SUBMITTER: Ding J 

PROVIDER: S-EPMC7158205 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacokinetics and Pharmacodynamics of Intensive Antituberculosis Treatment of Tuberculous Meningitis.

Ding Junjie J   Thuy Thuong Thuong Nguyen N   Pham Toi Van TV   Heemskerk Dorothee D   Pouplin Thomas T   Tran Chau Thi Hong CTH   Nguyen Mai Thi Hoang MTH   Nguyen Phu Hoan PH   Phan Loc Phu LP   Nguyen Chau Van Vinh CVV   Thwaites Guy G   Tarning Joel J  

Clinical pharmacology and therapeutics 20200229 4


The most effective antituberculosis drug treatment regimen for tuberculous meningitis is uncertain. We conducted a randomized controlled trial comparing standard treatment with a regimen intensified by rifampin 15 mg/kg and levofloxacin for the first 60 days. The intensified regimen did not improve survival or any other outcome. We therefore conducted a nested pharmacokinetic/pharmacodynamic study in 237 trial participants to define exposure-response relationships that might explain the trial re  ...[more]

Similar Datasets

| S-EPMC7927832 | biostudies-literature
| S-EPMC5850451 | biostudies-literature
| S-EPMC6761520 | biostudies-literature
2019-08-06 | GSE111459 | GEO
2019-08-06 | GSE122377 | GEO
2011-07-01 | GSE23074 | GEO
2011-06-30 | E-GEOD-23074 | biostudies-arrayexpress
| S-EPMC6355360 | biostudies-literature
| S-EPMC9989126 | biostudies-literature
| S-EPMC4916936 | biostudies-literature